Article Details

Lisata Therapeutics Announces Research License with Catalent - BioSpace

Retrieved on: 2025-04-15 18:56:02

Tags for this article:

Click the tags to see associated articles and topics

Lisata Therapeutics Announces Research License with Catalent - BioSpace. View article details on hiswai:

Excerpt

While ADCs utilize monoclonal antibodies to target tumor-specific antigens ensuring precise delivery of cytotoxic drugs to cancer cells while ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo